Compare Stocks › CME vs ORCL
CME Group Inc. (CME) vs Oracle Corporation (ORCL)
CME
CME Group Inc.
$310.71
VS
ORCL
Oracle Corporation
$155.52
Rewards
CME
- ★Gross margin of 100.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
- ★CME Group Inc. scores 77/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
- ★Free cash flow has grown at a 12.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
ORCL
- ★Oracle Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
- ★Gross margin of 67.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
- ★Oracle Corporation scores 71/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
Risks
CME
- ⚠Altman Z-Score of 0.53 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
- ⚠Insiders have sold $3.2M worth of stock in the past 3 months — significant insider liquidation.
ORCL
- ⚠Despite buyback spending, shares outstanding increased in 3 out of 4 years — stock-based compensation is offsetting repurchases.
- ⚠High leverage (4.15x debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
- ⚠Net debt/EBITDA of 4.5x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
Key Valuation Metrics
Learn more →CME
ORCL
Valuation
$4.19B
Free Cash Flow
$-22.30B
3.75%
FCF Yield
-4.99%
27.87
Trailing P/E
27.92
24.44
Forward P/E
19.51
Quality & Moat
10.10%
ROIC
8.22%
14.00%
ROE
31.86%
100.00%
Gross Margin
67.08%
0.80
PEG Ratio
1.14
Balance Sheet Safety
0.13
Debt / Equity
4.15
N/A
Interest Coverage
N/A
-0.17
Net Debt / EBITDA
4.48
1.67%
Dividend Yield
1.29%
CME: 8Ties: 2ORCL: 2
CMEORCL
Historical Fundamentals
Learn more →CME
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.
ORCL
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.
$1 Retained Earnings Test
Learn more →CME
$526.78
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$71.5M
Δ Market Cap
+$37.66B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
ORCL
$17.69
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$18.61B
Δ Market Cap
+$329.28B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Discounted Cash Flow (DCF) Analysis
Learn more →CME
47.6% Overvalued
Price is 47.6% above estimated fair value
Current Price: $310.71
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
Fair Value: $210.47
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
ORCL
235.9% Overvalued
Price is 235.9% above estimated fair value
Current Price: $155.52
Strongly undervalued
Strongly overvalued
Fair Value: $46.30
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
Reverse DCF — Market-Implied Growth
Learn more →CME
What growth rate is the market pricing in at $311?
+11.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.5%
The market implies +11.9% Owner Earnings growth, roughly in line with history — reasonably priced.
Standard FCF implies +11.5%, reflecting ongoing growth investment.
ORCL
Requires positive FCF to compute implied growth rate.
Economic Moat Score
Learn more →CME
77/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None
Wide moat driven primarily by margin stability. ROIC Consistency is the area most vulnerable to competitive pressure.
Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
ORCL
71/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None
Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.
Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
Forensic Accounting
Learn more →CME
-2.43
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
ORCL
-2.57
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Ownership Breakdown
Learn more →CME
Insiders 0.5%Institutions 92.6%Retail & Other 6.9%
No. of Institutional Holders2,297
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
ORCL
Insiders 40.5%Institutions 44.3%Retail & Other 15.1%
No. of Institutional Holders4,769
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.
Insider Buying Activity
Learn more →CME
0
Buys (3M)
2
Buys (12M)
Total value (12M): $144,331
SHEPARD WILLIAM R
Director
$72,336
@ $270.92 · 2025-06-25
SHEPARD WILLIAM R
Director
$71,995
@ $262.76 · 2025-03-26
SHEPARD WILLIAM R
Director
$325,798
@ $227.99 · 2025-01-16
SHEPARD WILLIAM R
Director
$324,198
@ $227.99 · 2025-01-16
BENESH KATHRYN
Director
$3,595
@ $239.67 · 2024-12-27
SHEPARD WILLIAM R
Director
$63,945
@ $218.99 · 2024-09-25
Open market purchases · includes direct & indirect ownership · excludes option exercises
ORCL
0
Buys (3M)
1
Buys (12M)
Total value (12M): $112,258
FAIRHEAD RONA ALISON
Director
$112,258
@ $233.87 · 2025-07-07
MOORMAN CHARLES W IV
Director
$947,913
@ $172.35 · 2025-02-12
Open market purchases · includes direct & indirect ownership · excludes option exercises
Open market purchases · includes direct & indirect ownership · excludes option exercises.
Insider Selling Activity
Learn more →CME
4
Sells (3M)
16
Sells (12M)
Total value (12M): $15.70M
VROMAN KENDAL L
Officer
$1.59M
@ $309.00 · 2026-03-12
DURKIN BRYAN T
Director
$1.30M
@ $309.65 · 2026-02-23
GEPSMAN MARTIN J
Director
$91,770
@ $305.90 · 2026-02-20
SUSKIND DENNIS A
Director
$224,400
@ $300.00 · 2026-02-06
DUFFY TERRENCE A
Chief Executive Officer
$6.74M
@ $269.55 · 2025-12-11
FORD HAROLD EUGENE JR
Director
$263,530
@ $263.53 · 2025-11-03
MARCUS JONATHAN L
General Counsel
$102,704
@ $262.00 · 2025-09-18
MCCOURT TIMOTHY FRANCIS
Officer
$98,476
@ $259.83 · 2025-09-16
MARCUS JONATHAN L
General Counsel
$97,369
@ $258.96 · 2025-09-16
CUTINHO SUNIL KIRAN
Chief Technology Officer
$3.23M
@ $271.47 · 2025-08-26
KAYE DANIEL G
Director
$141,210
@ $282.42 · 2025-05-22
MARCUS JONATHAN L
General Counsel
$108,225
@ $277.50 · 2025-05-20
LOCKETT PHYLLIS M
Director
$294,553
@ $277.88 · 2025-05-19
GEPSMAN MARTIN J
Director
$81,951
@ $273.17 · 2025-05-15
SUSKIND DENNIS A
Director
$271,280
@ $271.28 · 2025-04-29
GERDES LARRY G
Director
$1.06M
@ $265.11 · 2025-04-25
LUCAS DEBORAH J
Director
$385,425
@ $256.95 · 2025-03-14
DUFFY TERRENCE A
Chief Executive Officer
$7.78M
@ $259.18 · 2025-03-11
SPRAGUE SUZANNE
Chief Operating Officer
$385,249
@ $256.83 · 2025-03-03
PIELL HILDA HARRIS
Officer
$997,853
@ $250.47 · 2025-02-27
VROMAN KENDAL L
Officer
$1.27M
@ $250.00 · 2025-02-13
WINKLER JULIE
Officer
$2.89M
@ $249.17 · 2025-02-13
GEPSMAN MARTIN J
Director
$89,168
@ $222.92 · 2024-11-04
CUTINHO SUNIL KIRAN
Chief Technology Officer
$1.02M
@ $226.64 · 2024-10-30
BITSBERGER TIMOTHY S
Director
$226,957
@ $226.96 · 2024-10-30
MCCOURT TIMOTHY FRANCIS
Officer
$312,056
@ $227.11 · 2024-10-28
FITZPATRICK LYNNE
Chief Financial Officer
$163,610
@ $216.99 · 2024-09-13
DURKIN BRYAN T
Director
$1.63M
@ $214.59 · 2024-08-30
GLICKMAN DANIEL ROBERT
Director
$130,937
@ $201.44 · 2024-06-06
PIELL HILDA HARRIS
Officer
$1.50M
@ $210.35 · 2024-05-08
DUFFY TERRENCE A
Chief Executive Officer
$8.44M
@ $210.91 · 2024-04-29
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
ORCL
4
Sells (3M)
22
Sells (12M)
Total value (12M): $1.90B
MAGOUYRK CLAYTON M
Chief Executive Officer
$1.55M
@ $155.23 · 2026-02-09
KEHRING DOUGLAS A
Officer
$6.82M
@ $194.89 · 2026-01-15
HURA MARK
Officer
$2.95M
@ $196.89 · 2025-12-24
SELIGMAN NAOMI O
Director
$437,064
@ $196.61 · 2025-12-23
MAGOUYRK CLAYTON M
Chief Executive Officer
$1.93M
@ $192.52 · 2025-12-19
SMITH MARIA
Officer
$2.80M
@ $280.31 · 2025-10-23
MAGOUYRK CLAYTON M
Chief Executive Officer
$11.07M
@ $276.64 · 2025-10-21
LEVEY STUART A
Officer
$5.93M
@ $300.00 · 2025-10-10
SELIGMAN NAOMI O
Director
$641,958
@ $288.91 · 2025-09-26
SICILIA MICHAEL D
Officer
$10.87M
@ $321.16 · 2025-09-23
SICILIA MICHAEL D
Officer
$5.12M
@ $313.60 · 2025-09-16
MAGOUYRK CLAYTON M
President
$6.31M
@ $297.11 · 2025-09-12
SICILIA MICHAEL D
Officer
$4.04M
@ $254.48 · 2025-08-05
SELIGMAN NAOMI O
Director
$770,656
@ $233.32 · 2025-07-16
SMITH MARIA
Officer
$2.33M
@ $232.99 · 2025-07-03
CATZ SAFRA A
Chief Executive Officer
$267.24M
@ $212.01 · 2025-06-27
CATZ SAFRA A
Chief Executive Officer
$794.64M
@ $212.50 · 2025-06-26
CATZ SAFRA A
Chief Executive Officer
$764.01M
@ $206.77 · 2025-06-23
CONRADES GEORGE HENRY
Director
$1.74M
@ $213.49 · 2025-06-17
MAGOUYRK CLAYTON M
Officer
$3.21M
@ $214.10 · 2025-06-17
SELIGMAN NAOMI O
Director
$428,562
@ $149.53 · 2025-05-05
SELIGMAN NAOMI O
Director
$291,620
@ $145.81 · 2025-04-02
CATZ SAFRA A
Chief Executive Officer
$705.46M
@ $185.40 · 2025-01-24
SMITH MARIA
Officer
$1.04M
@ $165.00 · 2024-09-16
ELLISON LAWRENCE JOSEPH
Chief Technology Officer
$322.05M
@ $143.13 · 2024-07-16
SCREVEN EDWARD LLOYD
Officer
$60.58M
@ $141.91 · 2024-07-10
SCREVEN EDWARD LLOYD
Officer
$5.22M
@ $140.19 · 2024-06-26
SCREVEN EDWARD LLOYD
Officer
$34.04M
@ $144.30 · 2024-06-20
BOSKIN MICHAEL J
Director
$5.30M
@ $117.74 · 2024-05-07
CONRADES GEORGE HENRY
Director
$2.32M
@ $116.00 · 2024-05-03
CONRADES GEORGE HENRY
Director
$2.90M
@ $116.13 · 2024-05-01
CATZ SAFRA A
Chief Executive Officer
$346.77M
@ $126.10 · 2024-03-27
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.
🎭 Mr. Market's Mood
Learn more →CME
😐Neutral(59/100)
"Market is pricing this stock without strong emotion in either direction"
Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
ORCL
😨Fear(39/100)
"Market is pessimistic — investigate whether fears are temporary or structural"
Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
⚖️ Buffett Signal
Learn more →CME
⚪Awaiting DCF Data
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
DCF Margin of Safety: N/AMr. Market's Mood: Neutral (59)
ORCL
⚪Awaiting DCF Data
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)